Symbols

WAT

Waters·NYSE

--(--)

WAT fundamentals

WAT Q4 2025 Earnings

Waters (WAT) released its earnings on Feb 9, 2026: revenue was 932.36M (YoY +6.83%), beat estimates; EPS was 4.53 (YoY +10.49%), beat estimates.

Revenue / YoY

932.36M

+6.83%

EPS / YoY

4.53

+10.49%

Report date

Feb 9, 2026

WAT Earnings Call Summary for Q4,2025

Strong Q4 Finish: 7% revenue growth, driven by pharma and industrial segments. LC-MS instruments grew high single-digits.
BD Acquisition Impact: $3B+ contribution in 2026, but facing headwinds in China and U.S. government. Planning $50M+ synergies.
Empower Transition: 2 top pharma customers moved to subscription, reducing instrument sales but creating recurring revenue.
2026 Outlook: 5.3% blended growth, 28.1% margin, and $14.30-$14.50 EPS. Q1 guide reflects cautious start but strong execution potential.

Earnings

EPS

Revenue

Revenue & Expenses

WAT has released its 2025 Q4 earnings report, with revenue of 932.36M, reflecting a YoY change of 6.83%, and net profit of 225.21M, showing a YoY change of -2.67%. The Sankey diagram below clearly presents WAT's revenue sources and cost distribution.

Key Indicators

Waters (WAT) key financial stats and ratios, covering profitability, financial health, and leverage.

Income Statement

Waters (WAT)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.

Trend

Breakdown

Balance Sheet

Waters (WAT)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.

Trend

Breakdown

Cash Flow

Waters (WAT)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.

Trend

Breakdown